{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:49:02Z","timestamp":1790092142835,"version":"4.0.1"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Stent thrombosis remains a major complication following percutaneous coronary intervention, with significant morbidity and mortality implications. Despite advancements in drug-eluting stents and optimized pharmacotherapy, real-world registry data indicate that definite or probable stent thrombosis occurs in approximately 0.5% of percutaneous coronary intervention cases, with a 30-day mortality rate approaching 25% and a long-term risk exceeding 30% at 10 years. Stent thrombosis is classified based on timing into acute, subacute, late, and very late thrombosis, with subacute and very late stent thrombosis being the most prevalent. Clinical consequences include myocardial infarction, emergent revascularization, and heightened cardiovascular risk, necessitating timely recognition and intervention. Risk factors include patient characteristics, procedural variables, and lesion complexity, with recurrent stent thrombosis remaining a notable concern. This review explores the definitions, classifications, pathophysiology, and risk factors for stent thrombosis while discussing current strategies for prevention and management. Additionally, advancements in stent technology and pharmacologic interventions are examined, underscoring the need for a multidisciplinary approach to mitigate stent thrombosis incidence and improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1622235","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:36:09Z","timestamp":1761024969000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Stent thrombosis: a contemporary guide to definitions, risk factors, and management"],"prefix":"10.3389","volume":"12","author":[{"given":"Ambre","family":"Flowers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Evenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gabanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Affan","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez Ul","family":"Hassan Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.hlc.2019.10.009","article-title":"Incidence, predictors and clinical outcomes of stent thrombosis following percutaneous coronary intervention in contemporary practice","volume":"29","author":"Batchelor","year":"2020","journal-title":"Heart Lung Circ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e023276","DOI":"10.1161\/JAHA.121.023276","article-title":"Long-term outcomes and clinical predictors of mortality following occurrence of stent thrombosis","volume":"11","author":"Ishihara","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIR.0000000000000156","article-title":"2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American college of cardiology\/American heart association task force on clinical data standards (writing committee to develop cardiovascular endpoints data standards)","volume":"132","author":"Hicks","year":"2015","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.ijcha.2019.100427","article-title":"Acute and sub-acute stent thrombosis: frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre","volume":"26","author":"Tariq","year":"2020","journal-title":"IJC Heart Vasc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global European effort)","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4244\/EIJ-D-22-00049","article-title":"Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis","volume":"18","author":"Mohamed","year":"2022","journal-title":"EuroIntervention"},{"key":"B8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s11239-020-02184-7","article-title":"Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis","volume":"51","author":"Yang","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.4244\/EIJ-D-19-00219","article-title":"Incidence and predictors of outcomes after a first definite coronary stent thrombosis","volume":"16","author":"Tovar Forero","year":"2020","journal-title":"EuroIntervention"},{"key":"B10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.amjcard.2019.12.005","article-title":"Incidence and in-hospital outcomes of patients presenting with stent thrombosis (from the Japanese nationwide percutaneous coronary intervention registry)","volume":"125","author":"Ohno","year":"2020","journal-title":"Am J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00270-016-1513-0","article-title":"Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries","volume":"40","author":"Katsanos","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1107","DOI":"10.4244\/EIJ-D-19-00187","article-title":"Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery","volume":"15","author":"Bradaric","year":"2019","journal-title":"EuroIntervention"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e009870","DOI":"10.1161\/CIRCINTERVENTIONS.120.009870","article-title":"Calcium modification techniques in complex percutaneous coronary intervention","volume":"14","author":"Shah","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.amjcard.2021.06.031","article-title":"Incidence and predictors of stent thrombosis in patients treated with stents for coronary bifurcation narrowing (from the BIFURCAT registry)","volume":"156","author":"Franchin","year":"2021","journal-title":"Am J Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jcin.2021.05.019","article-title":"Stent expansion indexes to predict clinical outcomes","volume":"14","author":"Fujimura","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.37616\/2212-5043.1024","article-title":"Validity of the stent thrombosis risk score in predicting early stent thrombosis after primary percutaneous coronary intervention","volume":"32","author":"Kumar","year":"2020","journal-title":"J Saudi Heart Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.21037\/jtd-23-363","article-title":"The association of the systemic immune-inflammation index and stent thrombosis in myocardial infarction patients after coronary stent implantation\u2014a retrospectively study","volume":"15","author":"Zheng","year":"2023","journal-title":"J Thorac Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/eurheartj\/ehad362","article-title":"Personalised antiplatelet therapies for coronary artery disease: what the future holds","volume":"44","author":"Capodanno","year":"2023","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.3390\/jcm12237367","article-title":"Patient-related factors predicting stent thrombosis in percutaneous coronary interventions","volume":"12","author":"Anghel","year":"2023","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccl.2020.07.008","article-title":"Stent thrombosis after percutaneous coronary intervention","volume":"38","author":"Polimeni","year":"2020","journal-title":"Cardiol Clin"},{"key":"B21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3238\/arztebl.2020.0320","article-title":"Coronary stent thrombosis \u2014 predictors and prevention","volume":"117","author":"Ullrich","year":"2020","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12928-021-00754-x","article-title":"Drug-eluting stent thrombosis: current and future perspectives","volume":"36","author":"Kuramitsu","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.14744\/AnatolJCardiol.2020.69679","article-title":"Stent thrombosis during and after acute coronary syndromes: patient-related factors and operator-related factors","volume":"4","author":"Kamenik","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11239-018-1699-x","article-title":"Predictors of coronary stent thrombosis: a case\u2013control study","volume":"46","author":"Nascimento Silva","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/jcm14051413","article-title":"Body mass index and 10-year clinical outcomes after percutaneous coronary intervention\u2014interaction with age, sex, diabetic status and clinical presentation","volume":"14","author":"Ndrepepa","year":"2025","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.4244\/EIJ-D-19-00467","article-title":"The obesity paradox revisited: body mass index and \u00adlong-term outcomes after PCI from a large pooled patient-level database","volume":"15","author":"Wolny","year":"2020","journal-title":"EuroIntervention"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.21037\/cdt.2017.10.03","article-title":"Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation","volume":"7","author":"Jahangiri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.obpill.2023.100092","article-title":"Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: an obesity medicine association (OMA) clinical practice statement (CPS) 2023","volume":"8","author":"Bindlish","year":"2023","journal-title":"Obes Pillars"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00392-020-01604-1","article-title":"The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS trial","volume":"109","author":"Ono","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.jscai.2023.100971","article-title":"SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis","volume":"2","author":"Klein","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41598-023-50920-9","article-title":"High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation","volume":"14","author":"Lim","year":"2024","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.31083\/j.rcm2507238","article-title":"Five-year outcomes of bioresorbable stent therapy for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Yang","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/CIRCINTERVENTIONS.112.968271","article-title":"Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention","volume":"5","author":"Jakobsen","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4244\/EIJV10I10A196","article-title":"The impact of socio-economic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients","volume":"10","author":"Jones","year":"2015","journal-title":"EuroIntervention"},{"key":"B35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijcard.2009.04.033","article-title":"Impact of the community\u2019s socioeconomic status on characteristics and outcomes of patients undergoing percutaneous coronary intervention","volume":"144","author":"Shimony","year":"2010","journal-title":"Int J Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cjca.2021.09.029","article-title":"The association of socioeconomic factors with percutaneous coronary intervention outcomes","volume":"38","author":"Hannan","year":"2022","journal-title":"Can J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/00033197221130203","article-title":"Enhanced stent imaging system guided percutaneous coronary intervention is linked to optimize stent placement","volume":"75","author":"Avc\u0131","year":"2024","journal-title":"Angiology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijcard.2020.11.030","article-title":"Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: implications for short-term dual anti-platelet therapy","volume":"327","author":"Jinnouchi","year":"2021","journal-title":"Int J Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ccd.29922","article-title":"The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: a systematic review and meta-regression analysis","volume":"99","author":"Saito","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20517\/jca.2022.41","article-title":"Thrombosis and myocardial infarction: the role of bioresorbable scaffolds","volume":"3","author":"Leesar","year":"2023","journal-title":"J Cardiovasc Aging"},{"key":"B41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12959-023-00503-5","article-title":"Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry","volume":"21","author":"Hamana","year":"2023","journal-title":"Thromb J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/jcm12031238","article-title":"Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence","volume":"12","author":"Condello","year":"2023","journal-title":"J Clin Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.3390\/jcm12185892","article-title":"The usefulness of intracoronary imaging in patients with ST-segment elevation myocardial infarction","volume":"12","author":"Karamasis","year":"2023","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jacc.2024.12.009","article-title":"Management of coronary stent underexpansion","volume":"85","author":"Ng","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.1038\/s41598-020-63455-0","article-title":"A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/jcm14010056","article-title":"Platelets, biomarkers of coagulation and fibrinolysis, and early coronary stent thrombosis","volume":"14","author":"Galli","year":"2024","journal-title":"J Clin Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000535","article-title":"A review of systemic hematological manifestations and stent thrombosis","author":"Biggart","year":"2023","journal-title":"Cardiol Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jcin.2021.03.049","article-title":"Cancer patients have a higher risk of thrombotic and ischemic events after percutaneous coronary intervention","volume":"14","author":"Guo","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1111\/j.1538-7836.2010.04046.x","article-title":"Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome","volume":"8","author":"Heestermans","year":"2010","journal-title":"J Thromb Haemost"},{"key":"B50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","article-title":"Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses","volume":"167","author":"D\u2019Ascenzo","year":"2013","journal-title":"Int J Cardiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11239-009-0348-9","article-title":"Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent","volume":"29","author":"Granada","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/09537104.2016.1252836","article-title":"Bioreactivity of stent material: activation of platelets, coagulation, leukocytes and endothelial cell dysfunction in vitro","volume":"28","author":"Ollivier","year":"2017","journal-title":"Platelets"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"L\u00fcscher","year":"2007","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jacc.2011.10.903","article-title":"Role of endothelial shear stress in stent restenosis and thrombosis","volume":"59","author":"Koskinas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.amjcard.2003.08.017","article-title":"Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries","volume":"92","author":"Gijsen","year":"2003","journal-title":"Am J Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","article-title":"Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography","volume":"133","author":"Taniwaki","year":"2016","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1062529","DOI":"10.3389\/fbioe.2022.1062529","article-title":"Computational simulation of stent thrombosis induced by various degrees of stent malapposition","volume":"10","author":"Qu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/ATVBAHA.117.309728","article-title":"Local hemodynamic forces after stenting: implications on restenosis and thrombosis","volume":"37","author":"Ng","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","article-title":"Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study","volume":"129","author":"Witzenbichler","year":"2014","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/euhj.2001.2893","article-title":"Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial","volume":"23","author":"Mart\u00ednez-Elbal","year":"2002","journal-title":"Eur Heart J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/hrt.2009.183277","article-title":"Is direct stenting superior to stenting with predilation in patients treated with percutaneous coronary intervention? Results from a meta-analysis of 24 randomised controlled trials","volume":"96","author":"Piscione","year":"2010","journal-title":"Heart"},{"key":"B67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ccd.26861","article-title":"Does direct stenting with drug-eluting stents improve outcome? A meta-analysis of 10,900 patients","volume":"90","author":"Magalhaes","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jcin.2020.03.023","article-title":"Optimal stenting technique for complex coronary lesions","volume":"13","author":"Park","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjcard.2016.09.057","article-title":"Usefulness of post-coronary dilation to prevent recurrent myocardial infarction in patients treated with percutaneous coronary intervention for acute coronary syndrome (from the BASE ACS trial)","volume":"119","author":"Karjalainen","year":"2017","journal-title":"Am J Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e56348","DOI":"10.1371\/journal.pone.0056348","article-title":"Effect of stent inflation pressure and post-dilatation on the outcome of coronary artery intervention. A report of more than 90 000 stent implantations","volume":"8","author":"Fr\u00f6bert","year":"2013","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jcin.2016.06.056","article-title":"Contemporary approach to coronary bifurcation lesion treatment","volume":"9","author":"Sawaya","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"B73","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00392-021-01979-9","article-title":"Stenting techniques for coronary bifurcation disease: a systematic review and network meta-analysis demonstrates superiority of double-kissing crush in complex lesions","volume":"111","author":"Wang","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e025394","DOI":"10.1161\/JAHA.122.025394","article-title":"Systematic review and network meta-analysis comparing bifurcation techniques for percutaneous coronary intervention","volume":"11","author":"Park","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/eurheartj\/ehi135","article-title":"Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome","volume":"26","author":"Wenaweser","year":"2005","journal-title":"Eur Heart J"},{"key":"B76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.amjcard.2008.12.006","article-title":"Effectiveness of primary percutaneous coronary interventions for stent thrombosis","volume":"103","author":"Parodi","year":"2009","journal-title":"Am J Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ccd.25007","article-title":"Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis","volume":"82","author":"Waldo","year":"2013","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.amjcard.2011.07.044","article-title":"Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis","volume":"108","author":"Mahmoud","year":"2011","journal-title":"Am J Cardiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"435","DOI":"10.18433\/jpps32053","article-title":"Factors influencing 1st and 2nd generation drug-eluting stent performance: understanding the basic pharmaceutical drug-in-polymer formulation factors contributing to stent thrombosis do we really need to eliminate the polymer?","volume":"24","author":"Srdanovic","year":"2021","journal-title":"J Pharm Pharm Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jacc.2013.08.725","article-title":"Stent thrombosis with drug-eluting stents","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2018.3551","article-title":"Efficacy and safety of drug-eluting stents optimized for biocompatibility vs bare-metal stents with a single month of dual antiplatelet therapy: a meta-analysis","volume":"3","author":"Shah","year":"2018","journal-title":"JAMA Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2014.02.023","article-title":"Safety and efficacy of degradable vs. permanent polymer drug-eluting stents: a meta-analysis of 18,395 patients from randomized trials","volume":"173","author":"Wang","year":"2014","journal-title":"Int J Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ccd.30881","article-title":"The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long-term cardiovascular events","volume":"102","author":"Yaylak","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"B84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","article-title":"5-year outcomes after bioresorbable coronary scaffolds implanted with improved technique","volume":"82","author":"Stone","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcin.2024.08.050","article-title":"Early and late outcomes with the absorb bioresorbable vascular scaffold","volume":"18","author":"Power","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","article-title":"Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial","volume":"17","author":"Kerkmeijer","year":"2022","journal-title":"EuroIntervention"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","article-title":"Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial","volume":"140","author":"Kereiakes","year":"2019","journal-title":"Circulation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcin.2024.09.043","article-title":"A randomized comparison of bioheart sirolimus-eluting bioresorbable scaffold and everolimus-eluting stents","volume":"18","author":"Liu","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"B89","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B90","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12916-025-04254-0","article-title":"Firesorb bioresorbable scaffold for de novo coronary artery disease: 1-year clinical outcomes","volume":"23","author":"Jiang","year":"2025","journal-title":"BMC Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jama.294.7.819","article-title":"Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials","volume":"294","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"key":"B94","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ahj.2012.08.007","article-title":"Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials","volume":"165","author":"Park","year":"2013","journal-title":"Am Heart J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.amjcard.2015.03.059","article-title":"Meta-analysis of long-term clinical outcomes of everolimus-eluting stents","volume":"116","author":"Toyota","year":"2015","journal-title":"Am J Cardiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"Br Med J"},{"key":"B98","doi-asserted-by":"publisher","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"Br Med J"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"Von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ccd.24460","article-title":"Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound","volume":"81","author":"Armstrong","year":"2013","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"B101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jacc.2006.02.062","article-title":"Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques","volume":"48","author":"Kawasaki","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.jcmg.2017.09.008","article-title":"IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal","volume":"10","author":"Maehara","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging\u2013guided or angiography-guided complex PCI","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.jacc.2017.09.011","article-title":"Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention","volume":"70","author":"Yeh","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","article-title":"Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial","volume":"57","author":"Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/CIRCULATIONAHA.117.030190","article-title":"Randomized comparisons of double-dose clopidogrel or adjunctive cilostazol versus standard dual antiplatelet in patients with high posttreatment platelet reactivity: results of the CREATIVE trial","volume":"137","author":"Tang","year":"2018","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jacc.2008.12.025","article-title":"Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity","volume":"53","author":"Jeong","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000338812","article-title":"Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients","volume":"122","author":"Geng","year":"2012","journal-title":"Cardiology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e018184","DOI":"10.1161\/JAHA.120.018184","article-title":"Efficacy and safety of adjunctive cilostazol to clopidogrel-treated diabetic patients with symptomatic lower extremity artery disease in the prevention of ischemic vascular events","volume":"10","author":"Kalantzi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet Lond Engl"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.amjmed.2017.03.057","article-title":"Safety and efficacy of dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention","volume":"130","author":"Agarwal","year":"2017","journal-title":"Am J Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"B119","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00392-018-1252-0","article-title":"Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents","volume":"107","author":"Varenhorst","year":"2018","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e002568","DOI":"10.1161\/CIRCINTERVENTIONS.114.002568","article-title":"Fixed and modifiable correlates of drug-eluting stent thrombosis from a large all-comers registry: insights from ADAPT-DES","volume":"8","author":"Brodie","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"B121","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/clc.22289","article-title":"Adherence to dual antiplatelet therapy after coronary stenting: a systematic review","volume":"37","author":"Czarny","year":"2014","journal-title":"Clin Cardiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"200140","DOI":"10.1016\/j.ijcrp.2022.200140","article-title":"Income and antiplatelet adherence following percutaneous coronary intervention","volume":"14","author":"LaRosa","year":"2022","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"B123","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.jscai.2025.103607","article-title":"Factors contributing to low utilization of intracoronary imaging in clinical practice: a white paper","volume":"4","author":"Escaned","year":"2025","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B124","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40119-024-00372-7","article-title":"Patient and physician perspectives on the benefits and risks of antiplatelet therapy for acute coronary syndrome","volume":"13","author":"Cohen","year":"2024","journal-title":"Cardiol Ther"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e062158","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41551-021-00705-0","article-title":"Exosome-eluting stents for vascular healing after ischaemic injury","volume":"5","author":"Hu","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"B127","doi-asserted-by":"publisher","first-page":"8917","DOI":"10.1016\/j.biomaterials.2012.08.066","article-title":"Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin","volume":"33","author":"Lee","year":"2012","journal-title":"Biomaterials"},{"key":"B128","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1002\/smll.201402579","article-title":"In situ endothelialization: bioengineering considerations to translation","volume":"11","author":"Pang","year":"2015","journal-title":"Small"},{"key":"B129","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/rb\/rbv007","article-title":"Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury","volume":"2","author":"Wu","year":"2015","journal-title":"Regen Biomater"},{"key":"B130","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/jcm10010080","article-title":"The bioengineered combo dual-therapy CD34 antibody-covered sirolimus-eluting coronary stent in patients with chronic total occlusion evaluated by clinical outcome and optical coherence tomography imaging analysis","volume":"10","author":"Blessing","year":"2020","journal-title":"J Clin Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ajpath.2020.10.001","article-title":"Mechanisms of endothelial regeneration and vascular repair and their application to regenerative medicine","volume":"191","author":"Evans","year":"2021","journal-title":"Am J Pathol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fbioe.2020.00578","article-title":"Nitric oxide-producing cardiovascular stent coatings for prevention of thrombosis and restenosis","volume":"8","author":"Rao","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biomaterials.2019.03.007","article-title":"Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents","volume":"204","author":"Fan","year":"2019","journal-title":"Biomaterials"},{"key":"B134","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1073\/pnas.2003732117","article-title":"Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.actbio.2021.07.048","article-title":"S-nitroso human serum albumin as a nitric oxide donor in drug-eluting vascular grafts: biofunctionality and preclinical evaluation","volume":"134","author":"Enayati","year":"2021","journal-title":"Acta Biomater"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1805818","DOI":"10.1002\/adma.201805818","article-title":"Nitric-oxide-releasing biomaterial regulation of the stem cell microenvironment in regenerative medicine","volume":"32","author":"Midgley","year":"2020","journal-title":"Adv Mater"},{"key":"B137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/joic.12087","article-title":"Vascular endothelial growth factor\u2013bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model","volume":"27","author":"Takabatake","year":"2014","journal-title":"J Intervent Cardiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2020\/1458090","DOI":"10.34133\/2020\/1458090","article-title":"Hierarchical capillary coating to biofunctionlize drug-eluting stent for improving endothelium regeneration","volume":"2020","author":"Wang","year":"2020","journal-title":"Research"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.biomaterials.2012.11.006","article-title":"The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"B140","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.biomaterials.2015.12.033","article-title":"Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion","volume":"84","author":"Chan","year":"2016","journal-title":"Biomaterials"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/srep02366","article-title":"Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization","volume":"3","author":"Paul","year":"2013","journal-title":"Sci Rep"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1081881","DOI":"10.3389\/fphys.2022.1081881","article-title":"Vascular smooth muscle cells in intimal hyperplasia, an update","volume":"13","author":"D\u00e9glise","year":"2023","journal-title":"Front Physiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"19347","DOI":"10.1073\/pnas.1115945108","article-title":"In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid\u2013polymeric nanoparticles","volume":"108","author":"Chan","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B144","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1021\/acsomega.9b04118","article-title":"Titanium dioxide nanotube arrays for cardiovascular stent applications","volume":"5","author":"Junkar","year":"2020","journal-title":"ACS Omega"},{"key":"B145","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomater Basel Switz"},{"key":"B146","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.actbio.2018.01.038","article-title":"Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis","volume":"70","author":"Zhang","year":"2018","journal-title":"Acta Biomater"},{"key":"B147","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"key":"B148","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10557-024-07584-y","article-title":"Enhanced reendothelialization and thrombosis prevention with a new drug-eluting stent","volume":"4","author":"Cai","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"B149","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/biom9020069","article-title":"Surface-degradable drug-eluting stent with anticoagulation, antiproliferation, and endothelialization functions","volume":"9","author":"Hou","year":"2019","journal-title":"Biomolecules"},{"key":"B150","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11883-017-0654-1","article-title":"New-generation coronary stents: current data and future directions","volume":"19","author":"Kalra","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"B151","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.3390\/ma16216940","article-title":"Surface engineering of bioactive coatings for improved stent hemocompatibility: a comprehensive review","volume":"16","author":"Raikar","year":"2023","journal-title":"Materials"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/ijms25021078","article-title":"Coatings for cardiovascular stents\u2014an up-to-date review","volume":"25","author":"Udri\u0219te","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cjca.2020.01.027","article-title":"Machine learning to predict stent restenosis based on daily demographic, clinical, and angiographic characteristics","volume":"36","author":"Sampedro-G\u00f3mez","year":"2020","journal-title":"Can J Cardiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e029900","DOI":"10.1161\/JAHA.123.029900","article-title":"Dynamic prognosis prediction for patients on DAPT after drug-eluting stent implantation: model development and validation","volume":"13","author":"Li","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B155","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","article-title":"Amsterdam Investigator\u2013initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design","volume":"167","author":"Woudstra","year":"2014","journal-title":"Am Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1622235\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:36:11Z","timestamp":1761024971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1622235\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":155,"alternative-id":["10.3389\/fcvm.2025.1622235"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1622235","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1622235"}}